NYSE | FUND
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC.
The fund invests in public equity and fixed income markets across the globe.
It seeks to invest in securities of companies operating in the healthcare sector.
The fund also invests in pooled investment vehicles.
For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum.
It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index.
Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
Top 20 Holdings
| Name | Weight |
|---|---|
| Johnson & Johnson | 6.49% |
| Eli Lilly and Co | 3.52% |
| Medtronic PLC | 3.22% |
| McKesson Corp | 3.21% |
| Merck & Co Inc | 2.75% |
| Stryker Corp | 2.75% |
| Danaher Corp | 2.71% |
| Bristol-Myers Squibb Co | 2.68% |
| Cigna Corp | 2.13% |
| Horizon Therapeutics PLC | 1.96% |
| Zoetis Inc Class A | 1.90% |
| Becton, Dickinson and Co | 1.86% |
| HCA Healthcare Inc | 1.83% |
| Molina Healthcare Inc | 1.78% |
| Humana Inc | 1.66% |
| DexCom Inc | 1.62% |
| Welltower Inc | 1.57% |
| IDEXX Laboratories Inc | 1.46% |
| Boston Scientific Corp | 1.38% |
| Johnson Johnson | N/A% |